Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia

Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia

Mostrar outras versões (1)

There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.

Na minha lista:
Detalhes bibliográficos
Principais autores: Jacobson,B F, Schapkaitz,E, Mer,M, Louw,S, Haas,S, Buller,H R, Brenner,B, Abdool-Carrim,A T O, de Jong,P, Hsu,P, Jankelow,D, Lebos,M, Levy,B, Radford,H, Rowji,P, Redman,L, Sussman,M, van der Jagt,D, Wessels,P F, Williams,P G
Formato: Digital revista
Idioma:English
Publicado em: South African Medical Association 2021
Acesso em linha:http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021000500002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021000500002

Registros relacionados